Sort
11,323 grants matching “glioblastoma”
The roles of a unique GTP-binding protein/crosslinking enzyme in disease
$400,259Richard A. Cerione · Cornell University · R01 · FY2016 · CA
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$400,209David R Plas · University Of Cincinnati · R01 · FY2024 · CA
Project 2: Analyses of the human GBM microenvironment form clinical trial specimens treated with the oncolytic HSV, rQNestin34v.2
$400,081E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Macrophage polarization in glioma microenvironment
$400,079Yi Fan · University Of Pennsylvania · R01 · FY2018 · NS
SBIR PHASE I - TOPIC 405 - PROJECT TITLE: IN VIVO PHARMACOTYPING OF COMBINATION THERAPY IN PRIMARY BRAIN TUMORSFIRM FIXED PRICE - POP: 09/16/2020 - 0
$400,000Christian Knoopke · Lodestone Biomedical, Llc · N43 · FY2020 · CA
Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas
$400,000Gerald Francis Vovis · Modifi Biosciences Inc · R44 · FY2022 · CA
Mechanism and therapeutic potential of microglia regulation in glioblastoma
$400,000Peiwen Chen · Northwestern University At Chicago · R01 · FY2023 · NS
Development of a novel pan-cancer CAR-T product against AML and Glioblastoma
$400,000David Soler · Kure. Ai, Inc. · R43 · FY2024 · CA
TOP2A effects on transcription in gliomas: implications for personalized therapy
$400,000Adam M Sonabend · Columbia University Health Sciences · DP5 · FY2016 · OD
Mechanism and therapeutic potential of microglia regulation in glioblastoma
$400,000Peiwen Chen · Northwestern University At Chicago · R01 · FY2022 · NS
Developing a Novel Biologic Therapy to Eradicate Brain Cancer and Brain Metastasis
$400,000Donald Davidson · Creative Biotherapeutics, Llc · R43 · FY2024 · CA
The Immunosuppressive Function of Checkpoint Kinase 2 in Gliomas
$400,000Crismita Clement Dmello · Northwestern University At Chicago · R01 · FY2025 · NS
Phase 2 Study of Vascular-Targeted Prodrug (G-202) for the Treatment of Recurrent Glioblastoma
$400,000Santosh Kesari · Saint John'S Cancer Institute · R01 · FY2016 · FD
Phase 2 Study of Vascular-Targeted Prodrug (G-202) for the Treatment of Recurrent Glioblastoma
$400,000Santosh Kesari · University Of California, San Diego · R01 · FY2015 · FD
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
$400,000Jon O Nagy · Nanovalent Pharmaceuticals, Inc. · R42 · FY2023 · CA
A New Class of Magnetic Nanoparticles for Glioma Targeted Drug Delivery
$400,000Yuancheng Li · 5m Biomed, Llc · R41 · FY2021 · CA
Novel Drug Delivery Platform as Medical Countermeasure for treatment of Gastrointestinal Radiation Damage
$400,000Spencer Reid Marsh · Tiny Cargo Company, The · R41 · FY2023 · CA
The immunosuppressive function of Checkpoint kinase 2 in gliomas
$400,000Crismita Clement Dmello · Northwestern University At Chicago · R01 · FY2024 · NS
TOP2A effects on transcription in gliomas: implications for personalized therapy
$400,000Adam M Sonabend · Columbia University Health Sciences · DP5 · FY2015 · OD
Development of small molecule RPN13 inhibitors for Treatment of Glioblastoma
$400,000Ravi Kumar Anchoori · Up Therapeutics, Inc. · R41 · FY2022 · CA
Treatment of Glioblastoma: the combination of fluorescence guided surgery and photodynamic therapy
$400,000William R Potter · Photolitec, Llc · R44 · FY2020 · CA
ISS: Leveraging Microgravity to Study Immunomechanics in Cancer-Myeloid Organoids
$400,000Meenal Datta · University Of Notre Dame · · FY2024 · ENG
Targeting glioblastoma with CM93, a novel EGFR inhibitor with exceptional brain penetration
$400,000Jean Zhao · Crimson Biopharm Inc · R41 · FY2023 · CA
Cooperating pathways in glioblastoma stem cells
$400,000Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R56 · FY2017 · NS
Detecting invading glioma cells through in vivo molecular imaging of the cell sur
$400,000Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2009 · NS